Measuring the harm of illicit drug use on friends and family

NAD Publication

Volumn 28, Issue 2, 2011, Pages 105-121

  Melberg, Hans Olav ^a   Hakkarainen, Pekka ^b   Hotjborg, Esben ^c   Jääskeläinen, Märke ^b   Skretting, Astrid ^d   Ramstedt, Mats ^e   Rosenqvist, Pia ^f  

^a UNIVERSITY OF OSLO   (Norway)

^b THL   (Finland)

^c AARHUS UNIVERSITY   (Denmark)

^d SIRUS   (Norway)

^e STOCKHOLM UNIVERSITY   (Sweden)

^f Nordic Center for Welfare and Social Issues   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874339915     PISSN: 03597024     EISSN: None     Source Type: Book Series    
DOI: 10.2478/v10199-011-0012-5     Document Type: Article

References (26)

1. Braunsberger, K. & Wybenga, H. & Gates, R. (2007): A comparison of reliability between telephone and web-based surveys, Journal of Business Research 60:758-764
2. Couper, M. P. (2000): Web Surveys: A review of issues and approaches, Public Opinion Quarterly 64:464-494
3. Culyer, A. & Eaton, G. & Godfrey, C. & Koustolioutsos, H. & McDougall, C. (2002): Economics & Social cost of substance misuse in the Jnited Kingdom: Review of the methodological and empirical studies of the economic and social costs of illicit drugs. York, University of York, Centre for Criminal Justice, Economics, and Psychology
4. Davidson, T. & Levin, L-Å. (2010): Is the Societal Approach Wide Enough to Include Relatives? Incorporating Relatives' Costs and Effects in a Cost-Effectiveness Analysis, Applied Health Economics & Health Policy 8(1):25-35
5. Diener, A. & O'Brien, B. & Gafni, A. (1998): Health care contingent valuation studies: A review and classification of the literature, Health Economics 7(4):313-326
6. French, M. T. P. & Martin, R. B. B. (1996): The Costs of Drugs Abuse Consequences: A summary of Research Findings. Journal of Substance Abuse Treatment 13:453-466
7. Hakkarainen, P. & Tigerstedt, C. & Tammi, T. (2007): Dual-track drug policy: Normalization of the drug problem in Finland. Drugs: education, prevention and policy 14:543-558
8. Harwood, H. & Fountain, D. & Livermore, G. (1998): The Economic Cost of Alcohol and Drug Abuse in the United States, 1992. National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institute on Health, U. S. Department of Health and Human Services. NIH Pub. No. 98-4327. Rockville. MD: National Institute on Drug Abuse
9. Jones, A. (2007): Applied Econometrics for Health Economists: A Practical Guide, Radcliffe Publishing
10. Kleiman, M. A. R. (1999): Economic cost' measurements, damage minimization and drug abuse control policy, Addiction 94(5):638-641
11. Klose, T. (1999): The contingent valuation method in health care, Health Policy 47(2):97-123
12. MacDonald, Z. & Tinsley, L. & Collingwood, J. & Jamieson, P. & Pudney, S. (2005): Measuring the harm from illegal drugs using the drug harm index. United Kingdom Home Office. Available: http://www.homeoffice. gov. uk/rds/pdfs05/rdsolr2405.pdf
13. McFadden, M. (2006): The Australian Federal Police drug harm index: A new methodology for quantifying success in combating drug use. Australian Journal of Public Administration 65:68-81 (Pubitemid 44878892)
14. Melberg, H. O. (2010): Conceptual problems with studies of the social cost of alcohol and drug use. Nordic Studies on Alcohol and Drugs 27(4):287-304
15. Moore, T. J. & Caulkins, J. P. (2006): How costof-illness studies can be made more useful for illicit drug policy analysis. Applied Health Economics and Health Policy 5(2):75-85 (Pubitemid 44214766)
16. Nutt, D. J. & King, L. A., Phillips, L. D. (2010): Drug Harms in the UK: A multicirteria decision analysis. The Lancet 376:1558-65
17. Olsson, B. & Stymme, A. & Hakkarainen, P. & Schmidt, D. & Skretting, A. & Valsson, K. (1997): The Nordic drug scene in the 1990s - Recent trends. Nordisk alkohol-& narkotikatidskrift 14(English Supplement):64-82
18. Praag, B. & Ferrer-i-Carbonell, A. (2001): Agedifferentiated QALY losses, IZA Discussion Paper no 314, Bonn, Germany
19. Ritter, A. (2007): Comparing Alcohol Policies Between Countries: Science or Silliness? PLoS Medicine 4(4):e153. doi:10.1371/journal.pmed.0040153 (Pubitemid 46658760)
20. Reuter, P. (1999): Are calculations of the economic costs of drug abuse either possible or useful? Addiction 94:635-638
21. Single, E. & Robson, L. & Xie, X. & Rehm, J. (1998): The Economic costs of alcohol, tobacco, and illicit drugs in Canada, 1992. Addiction 93:991-1006 (Pubitemid 28320991)
22. Smith, R. (2003): Construction of the contingent valuation market in health care: a critical assessment. Health Economics 12:609-628 (Pubitemid 37038358)
23. Smith, R. (2007): use, option and externality values: are contingent valuation studies in health care mis-specified? Health Economics 16:861-869 (Pubitemid 47215135)
24. Smith, R. (2008): Contingent valuation in health care: does it matter how the 'good' is described? Health Economics 17(5):607-617 (Pubitemid 351772341)
25. Tammi, T. (2007): Medicalising prohibition. Harm reduction in Finnish and international drug policy. Helsinki: stakes
26. Zarkin, G. A. & Cates, S. C. & Bala M. V. (2000): Estimating the willingness to pay for drug abuse treatment: a pilot study. Journal of substance abuse treatment 18(2):149-159. (Pubitemid 30123098)